Bostoncellstandards
Boston, US · 1 known investors
Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.
Founders & leadership
SB
Steve Bogen MD PhDinCo-Founder & CEO
Investors · 1
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $219.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $301.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $228.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $145.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2006 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2004 | $863.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $225.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Bostoncellstandards do?
- Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.
- Who founded Bostoncellstandards?
- Bostoncellstandards was founded by Steve Bogen MD PhD.
- Who are Bostoncellstandards's investors?
- Bostoncellstandards's investors include Bantam Group.
- Where is Bostoncellstandards headquartered?
- Bostoncellstandards is headquartered in Boston, US.